Effect of point-spread function reconstruction for indeterminate PSMA-RADS-3A lesions on PSMA-targeted PET imaging of men with prostate cancer
- Sprache
-
Englisch
- Identifier
-
1267254890
- Beteiligte Personen und Organisationen
-
Khatri, Wajahat
Chung, Hyun Woo
Werner, Rudolf A.
Leal, Jeffrey P.
Pienta, Kenneth J.
Lodge, Martin A.
Gorin, Michael A.
Pomper, Martin G.
Rowe, Steven P.
- DOI
-
10.3390/diagnostics11040665
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
27.10.20232023, 19:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Khatri, Wajahat
- Chung, Hyun Woo
- Werner, Rudolf A.
- Leal, Jeffrey P.
- Pienta, Kenneth J.
- Lodge, Martin A.
- Gorin, Michael A.
- Pomper, Martin G.
- Rowe, Steven P.
Ähnliche Objekte (12)
Combination therapies to enhance the efficacy of PSMA-targeted radioligand therapy in prostate cancer
Expression of prostate specific membrane antigen (PSMA) in breast cancer = Die Expression des prostataspezifischen Membranantigens (PSMA) beim Mammakarzinom
\(^18}\)F-labeled, PSMA-targeted radiotracers: leveraging the advantages of radiofluorination for prostate cancer molecular imaging
⁶⁸Ga-PSMA PET for the assessment of metastatic prostate cancer
Patterns of uptake of prostate-specific membrane antigen (PSMA)-targeted \(^18}\)F-DCFPyL in peripheral ganglia
Results from extended lymphadenectomies with [111In]PSMA-617 for intraoperative detection of PSMA-PET/CT-positive nodal metastatic prostate cancer
The PSMA-11-derived hybrid molecule PSMA-914 specifically identifies prostate cancer by preoperative PET/CT and intraoperative fluorescence imaging
PSMA inhibitor-based radiopharmaceuticals for diagnosis and therapy of prostate cancer
Evaluation of prostatic lesions by simultaneous [68Ga]Ga-PSMA-11 PET/MRI
Prostate specific membrane antigen (PSMA) expression in non-small cell lung cancer
PSMA-targeting radiopharmaceuticals for prostate cancer Therapy: recent developments and future perspectives
Test-retest repeatability of organ uptake on PSMA‐targeted 18F‐DCFPyL PET/CT in patients with prostate cancer
Combination therapies to enhance the efficacy of PSMA-targeted radioligand therapy in prostate cancer
Expression of prostate specific membrane antigen (PSMA) in breast cancer = Die Expression des prostataspezifischen Membranantigens (PSMA) beim Mammakarzinom
\(^18}\)F-labeled, PSMA-targeted radiotracers: leveraging the advantages of radiofluorination for prostate cancer molecular imaging
⁶⁸Ga-PSMA PET for the assessment of metastatic prostate cancer
Patterns of uptake of prostate-specific membrane antigen (PSMA)-targeted \(^18}\)F-DCFPyL in peripheral ganglia
Results from extended lymphadenectomies with [111In]PSMA-617 for intraoperative detection of PSMA-PET/CT-positive nodal metastatic prostate cancer
The PSMA-11-derived hybrid molecule PSMA-914 specifically identifies prostate cancer by preoperative PET/CT and intraoperative fluorescence imaging
PSMA inhibitor-based radiopharmaceuticals for diagnosis and therapy of prostate cancer
Evaluation of prostatic lesions by simultaneous [68Ga]Ga-PSMA-11 PET/MRI
Prostate specific membrane antigen (PSMA) expression in non-small cell lung cancer
PSMA-targeting radiopharmaceuticals for prostate cancer Therapy: recent developments and future perspectives
Test-retest repeatability of organ uptake on PSMA‐targeted 18F‐DCFPyL PET/CT in patients with prostate cancer
Combination therapies to enhance the efficacy of PSMA-targeted radioligand therapy in prostate cancer
Expression of prostate specific membrane antigen (PSMA) in breast cancer = Die Expression des prostataspezifischen Membranantigens (PSMA) beim Mammakarzinom
\(^18}\)F-labeled, PSMA-targeted radiotracers: leveraging the advantages of radiofluorination for prostate cancer molecular imaging
⁶⁸Ga-PSMA PET for the assessment of metastatic prostate cancer
Patterns of uptake of prostate-specific membrane antigen (PSMA)-targeted \(^18}\)F-DCFPyL in peripheral ganglia
Results from extended lymphadenectomies with [111In]PSMA-617 for intraoperative detection of PSMA-PET/CT-positive nodal metastatic prostate cancer
The PSMA-11-derived hybrid molecule PSMA-914 specifically identifies prostate cancer by preoperative PET/CT and intraoperative fluorescence imaging
PSMA inhibitor-based radiopharmaceuticals for diagnosis and therapy of prostate cancer
Evaluation of prostatic lesions by simultaneous [68Ga]Ga-PSMA-11 PET/MRI
Prostate specific membrane antigen (PSMA) expression in non-small cell lung cancer
PSMA-targeting radiopharmaceuticals for prostate cancer Therapy: recent developments and future perspectives